Keywords: کارودیلول; Carvedilol; Dronedarone; Pharmacokinetics; Drug interaction; CYP2D6;
مقالات ISI کارودیلول (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کارودیلول; Beta-blocker; cardiovascular; carvedilol; hemodialysis; hypotension; metoprolol; mortality; blood pressure; intradialytic hypotension (IDH); dialyzability; end-stage renal disease (ESRD); pharmacoepidemiology;
Keywords: کارودیلول; Carvedilol; β-blocker; Antibacterial activity; Mechanism of action; Drug inactivation;
Keywords: کارودیلول; BAC; baclofen; CAR; carvedilol; CTZ; cetirizine; CS; chiral selector; CPA; chlorpheniramine; CIT; citalopram; FLU; fluoxetine; HXZ; Hydroxyzine; HP-α-CD; hydroxypropyl-α-cyclodextrin; HP-β-CD; hydroxypropyl-β-cyclodextrin; MD; maltodextrin; PFM; parti
Keywords: کارودیلول; Carvedilol; Solid SMEDDS; Hot-melt extrusion; Enteric release;
Keywords: کارودیلول; Adriamycin; Cardiotoxicity; Captopril; Carvedilol;
Keywords: کارودیلول; Chronic heart failure; Bisoprolol; Carvedilol; High sensitivity troponin T; Forced expiratory volume in the first second;
Keywords: کارودیلول; HVPG; hepatic venous pressure gradient; NSBB; non-selective beta blockers; EBL; endoscopic band ligation; CYP; Cytochrome P450; Beta blockers; Esophageal varices; Cytochrome P450; Gender; Propranolol; Carvedilol;
Keywords: کارودیلول; Cocaine use disorder; Carvedilol; Clinical trial; Adrenergic blocker;
Keywords: کارودیلول; Pulmonary vein; Automaticity; Adrenoceptor; Carvedilol;
Keywords: کارودیلول; Carvedilol; Eudragit® RS 100; Mucoadhesion; Nanocapsules; Poly(ε-caprolactone); Sublingual permeability;
Keywords: کارودیلول; Losartan; Rosuvastatin; Carvedilol; Hydralazine; Left ventricular hypertrophy; Heart failure; Oxidative stress; Trx-1; Grx-3; Prx-2; Caspase-3; BNP;
Keywords: کارودیلول; Carvedilol; Oxaliplatin; Mitochondrial dysfunction; Peripheral neuropathy & dorsal root ganglion;
Keywords: کارودیلول; Dilated cardiomyopathy; Carvedilol; Brain natriuretic peptide; Heart failure; Left ventricular reverse remodeling
Keywords: کارودیلول; solid-state NMR; ab initio calculations; crystal structure; polymorphism; spectroscopy; carvedilol;
Keywords: کارودیلول; Thin film; Sorptive phase; Solid state spectrofluorimetry; Carvedilol; Plasma; Methylmethacrylate-ethyleneglycol dimethacrylate polymer
Keywords: کارودیلول; Hollow mesoporous silica; Drug delivery; Sustained release; Insoluble drug; Carvedilol; Fenofibrate
Keywords: کارودیلول; Carvedilol; Buccal delivery; Solidification of microemulsions; Laminated sponges
Keywords: کارودیلول; Antihypertensive drugs; Beta-blockers; Carvedilol; Chronic intermittent hypoxia; Telemetry;
Keywords: کارودیلول; Carvedilol; Cyclodextrin; Tartaric acid; Ionization process; Water soluble polymer; Dissolution enhancement
Keywords: کارودیلول; BPV; blood pressure variability; MI; myocardial infarct; HRV; heart rate variability; VLF; very low frequency; LF; low frequency; HF; high frequency; SO; sham operated; Plac; placebo; Carv; carvedilol; Arterial blood pressure; Autonomic nervous system; Po
Carvedilol-Imprinted Polymer: Rational design and selectivity studies
Keywords: کارودیلول; DFT; Theoretical calculations; Rational design; Carvedilol; Molecularly imprinted polymer;
Characterization and molecular basis for the block of Kv1.3 channels induced by carvedilol in HEK293 cells
Keywords: کارودیلول; Carvedilol; Kv1.3 channels; Hyperpolarizing shift; Closed- and open-channel block, molecular determinants;
Nanoemulsion-based film formulation for transdermal delivery of carvedilol
Keywords: کارودیلول; Nanoemulsion; Transdermal; Film; Chitosan; Penetration enhancers; Carvedilol; HPMC; hydroxypropyl methylcellulose; PEG; polyethylene glycol; Jss; steady state flux; p; permeability coefficient; SC; stratum corneum; Cs; Saturation solubility; IPM; isopropy
Novel metabolites from Cunninghamella elegans as a microbial model of the β-blocker carvedilol biotransformation in the environment
Keywords: کارودیلول; Carvedilol; β-Blocker; Biodegradation pathway; Filamentous fungi; Cytochrome P450;
Cyclodextrin-based poly(pseudo)rotaxanes for transdermal delivery of carvedilol
Keywords: کارودیلول; Carvedilol; Poly(pseudo)rotaxanes; Rheology; Controlled release; Transdermal application; Supramolecular gels;
Integration of in vitro biorelevant dissolution and in silico PBPK model of carvedilol to predict bioequivalence of oral drug products
Keywords: کارودیلول; Virtual bioequivalence; Carvedilol; In vitro-in silico-in vivo; PBPK;
Preparation of poloxamer-based nanofibers for enhanced dissolution of carvedilol
Keywords: کارودیلول; Carvedilol; Dissolution rate; Electrospinning; Nanofibers; Poloxamer;
Quality by design approach to screen the formulation and process variables influencing the characteristics of carvedilol solid lipid nanoparticles
Keywords: کارودیلول; Carvedilol; Gelucire; Entrapment efficiency; Plackett-burman design; Solid nanostructured lipid particles;
Store depletion-induced h-channel plasticity rescues a channelopathy linked to Alzheimer's disease
Keywords: کارودیلول; HCN channel; Endoplasmic reticulum; TRIP8b; Carvedilol; Electron microscopy; Patch-clamp; Array tomography;
β-arrestin-biased agonism of β-adrenergic receptor regulates Dicer-mediated microRNA maturation to promote cardioprotective signaling
Keywords: کارودیلول; βARs; β-adrenergic receptors; β-blockers; β-adrenergic receptor antagonists; β-miRs; β-adrenergic receptor/β-arrestin-regulated miRs; Carv; carvedilol; GPCR; G protein-coupled receptor; GRK; G protein-coupled receptor kinase; KO; knockout; MiRNAs o
Carvedilol abrogates hypoxia-induced oxidative stress and neuroinflammation in microglial BV2 cells
Keywords: کارودیلول; Hypoxia; Carvedilol; Microglia; NF-κB; IL-1β;
Carvedilol can attenuate histamine-induced paw edema and formaldehyde-induced arthritis in rats without risk of gastric irritation
Keywords: کارودیلول; Carvedilol; Lornoxicam; Arthritis; Gastric ulceration;
Comparative study on stabilizing ability of food protein, non-ionic surfactant and anionic surfactant on BCS type II drug carvedilol loaded nanosuspension: Physicochemical and pharmacokinetic investigation
Keywords: کارودیلول; Carvedilol; Nanosuspensions; Whey protein isolate; Antisolvent precipitation-ultrasonication; Stabilizers; Pharmacokinetics;
Heart rate control by carvedilol in Japanese patients with chronic atrial fibrillation: The AF Carvedilol study
Keywords: کارودیلول; Atrial fibrillation; Carvedilol; Heart rate control;
Microbial detoxification of carvedilol, a β-adrenergic antagonist, by the filamentous fungus Cunninghamella echinulata
Keywords: کارودیلول; Carvedilol; β-Blocker; Microbial degradation; Filamentous fungi; Detoxification; Phospholipids;
Carvedilol exacerbate gentamicin-induced kidney mitochondrial alterations in adult rat
Keywords: کارودیلول; Carvedilol; Gentamicin; Nephrotoxicity; Mitochondria; Carboxylic acid; Cardiolipin;
Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites
Keywords: کارودیلول; Carvedilol; Non-selective beta-blockers; Ascites; Decompensated liver disease;
Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients
Keywords: کارودیلول; Carvedilol; Enantiomers; Population pharmacokinetics; Type 2 diabetes; Stereoselective metabolism;
Carvedilol suppresses cartilage matrix destruction
Keywords: کارودیلول; Carvedilol; NF-κB; Collagen type â
¡; MMP-1; Osteoarthritis (OA);
Spectrophotometric methods for simultaneous determination of Carvedilol and Hydrochlorothiazide in combined dosage form
Keywords: کارودیلول; Carvedilol; Hydrochlorothiazide; Dual wavelength method; Q-absorbance method; Absorbance ratio method; Spectrophotometry;
Carvedilol protects the kidneys of tumor-bearing mice without impairing the biodistribution or the genotoxicity of cisplatin
Keywords: کارودیلول; Cisplatin; Carvedilol; Nephroprotection; Genotoxicity; Biodistribution;
Effects of carvedilol on ventricular remodeling and the expression of β3-adrenergic receptor in a diabetic rat model subjected myocardial infarction
Keywords: کارودیلول; Myocardial infarction; Type 2 diabetes; β3-AR; Gi; Carvedilol;
Carvedilol protects bone marrow stem cells against hydrogen peroxide-induced cell death via PI3K-AKT pathway
Keywords: کارودیلول; Carvedilol; Bone marrow stem cells; Spinal cord injury; Oxidative stress; PI3K-Akt pathway
Application of substrate depletion assay to evaluation of CYP isoforms responsible for stereoselective metabolism of carvedilol
Keywords: کارودیلول; Carvedilol; Stereoselective metabolism; Enantiomer; Cytochrome P450; Oxidation;
Application of failure mode and effects analysis in quality by design approach for formulation of carvedilol compression coated tablets
Keywords: کارودیلول; FMEA; Carvedilol; Compression coating; Quality by design
Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: Application to a clinical pharmacokinetic study
Keywords: کارودیلول; Carvedilol; Enantiomers; Pharmacokinetics; Metabolism; Plasma; Diabetes;
Carvedilol attenuates paraquat-induced lung injury by inhibition of proinflammatory cytokines, chemokine MCP-1, NF-κB activation and oxidative stress mediators
Keywords: کارودیلول; Carvedilol; Paraquat; Lung injury; Proinflammatory cytokines; Inflammation; Oxidative stress;
Original ArticleCarvedilol-Enriched Cold Oxygenated Blood Cardioplegia Improves Left Ventricular Diastolic Function After Weaning From Cardiopulmonary Bypass
Keywords: کارودیلول; carvedilol; cardiac function; cardioplegia; cardiopulmonary bypass; oxidative stress;
Original InvestigationDialysisThe β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial
Keywords: کارودیلول; Beta-blocker; carvedilol; Dilatrend; adrenergic receptor blockade; dialysis; hemodialysis; cardiovascular disease (CVD); cardiovascular mortality; intradialytic hypotension (IDH); bradycardia; feasibility study; study recruitment; drug tolerability; rando